Category: Case Studies

Case study: Finding the best AI headshot generator for privacy-focused remote teams

March 6, 2024

Artificial Intelligence (AI) is rapidly reshaping what the workplace of the future looks like, making the balance between innovation and privacy crucial. Array Insights teamed up with Dreamwave to showcase how companies can leverage AI to advance the future of work, without compromising our shared vision for personal privacy and ethical AI.   The Challenge: Corporate headshots and branding for a remote team Adapting to a remote work model post-pandemic posed…

Read More

Case Study: Pancreatic Cancer Action Network (PanCAN)

September 12, 2023

PanCAN and Array Insights are developing a first-of-its-kind clinical data federation. The federation will use novel machine-learning technologies to help the medical community gain a deeper understanding of how pancreatic cancer manifests in a more representative population.

Read More

Case Study: The Fatty Liver Foundation Develops an AI Risk Stratification Tool

August 28, 2023

FLF and Array Insights are joining forces to use machine-learning technology to help patients and their primary care physicians assess risk for NAFLD and NASH.

Read More

Case Study: The Kidney Cancer Association Builds a Next-Gen Clinical Data Federation

August 22, 2023

Despite significant advances in the past few decades, many kidney cancer treatments aren’t effective for patients. These patients are counting on research breakthroughs to ensure longer, better lives.

Read More

Building a Next-Gen Clinical Data Federation: Q&A with Gretchen E. Vaughan of the Kidney Cancer Association

April 25, 2023

What does it mean to be a leading patient advocacy group? For the Kidney Cancer Association, the mission is clear: “serving and empowering patients and caregivers, and leading change through advocacy, research and education.” Through a unique and robust clinical data strategy, the KCA provides an example of how a next-generation patient advocacy group can enable much-needed breakthroughs. Many kidney cancer treatments are ineffective: only about 25-40% of kidney cancer…

Read More